BioSpecifics Technologies Corp. announced that its Board of Directors appointed Mike Sherman and Corey Fishman to serve as Independent Directors, effective immediately. Mike Sherman and Corey Fishman will both join the Board's Audit Committee, with Mr. Sherman serving as an "audit committee financial expert." Corey Fishman will also join the Intellectual Property Committee. Mike Sherman is currently Chief Executive Officer of Chimerix Inc. Before joining the Chimerix in 2019, he served as Chief Executive Officer of Endocyte Inc. Corey Fishman has served as Chief Executive Officer and Director of Iterum Therapeutics plc, a publicly-traded biopharmaceutical company, since he founded the company in 2015.